Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride

J Cereb Blood Flow Metab. 1993 Mar;13(2):310-4. doi: 10.1038/jcbfm.1993.39.

Abstract

The effect of age on human striatal dopamine D2 receptors was investigated with positron emission tomography (PET) using [11C]raclopride as a radioligand. Twenty-one healthy volunteers aged from 20 to 81 years were studied. An equilibrium method was applied and two separate PET scans with different specific activities of [11C]raclopride were performed. The maximal number of receptors (Bmax) and their dissociation constant (Kd) were calculated using Scatchard analysis. There was an age-dependent decline in the Bmax (r = -0.49; p = 0.02) of striatal D2 receptors while the Kd remained unchanged. The results show that there is an age-related loss of striatal D2 receptors, which, together with other changes in the brain nigrostriatal dopaminergic system, may contribute to extrapyramidal symptoms associated with aging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / physiology*
  • Carbon Radioisotopes
  • Cerebellum / diagnostic imaging
  • Cerebellum / metabolism
  • Dopamine D2 Receptor Antagonists
  • Female
  • Humans
  • Male
  • Middle Aged
  • Raclopride
  • Receptors, Dopamine D2 / metabolism*
  • Salicylamides
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / metabolism*
  • Tomography, Emission-Computed

Substances

  • Carbon Radioisotopes
  • Dopamine D2 Receptor Antagonists
  • Receptors, Dopamine D2
  • Salicylamides
  • Raclopride